Guizhou Sanli Pharmaceutical Co.,Ltd (SHSE:603439) announces a share repurchase program. Under the program, the company will repurchase up to CNY 40 million worth of its shares. The repurchase price will not be more than CNY 26.42 per share.

The repurchased shares will be used for ESOP or equity incentives. The repurchase program is valid for 12 months.